| scholarly article | Q13442814 |
| P2093 | author name string | Murat Çabalar | |
| Vildan Yayla | |||
| Vildan Güzel | |||
| Asuman Gedikbaşi | |||
| Özlem Selçuk | |||
| Samiye Uysal | |||
| P2860 | cites work | Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein | Q73149965 |
| Serum S-100 protein, relationship to clinical outcome in acute stroke | Q73688203 | ||
| Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke | Q81013808 | ||
| Neuron-specific enolase and S 100B protein as predictors of outcome in ischaemic stroke | Q82478383 | ||
| Intracellular and extracellular roles of S100 proteins | Q28184555 | ||
| S100B expression in and effects on microglia | Q28579350 | ||
| S100B in brain damage and neurodegeneration | Q28593720 | ||
| Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study | Q29615116 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| Stroke: how large a public health problem, and how can the neurologist help? | Q33659066 | ||
| Serum S-100B protein as a molecular marker in severe traumatic brain injury | Q34268092 | ||
| Systemic markers of inflammation are independently associated with S100B concentration: results of an observational study in subjects with acute ischaemic stroke | Q34321555 | ||
| Correlation between Serum D-Dimer Level and Volume in Acute Ischemic Stroke | Q35503036 | ||
| Progression in acute stroke: value of the initial NIH stroke scale score on patient stratification in future trials | Q40810789 | ||
| Serum S-100B protein in severe head injury | Q44390422 | ||
| Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage | Q48194312 | ||
| Correlation of computed tomography findings and serum brain damage markers following severe head injury | Q48353642 | ||
| Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients | Q48390207 | ||
| S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction | Q48613055 | ||
| S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke | Q48613065 | ||
| Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic stroke | Q48722684 | ||
| Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction | Q48810764 | ||
| Protein S-100B: a serum marker for ischemic and infectious injury of cerebral tissue | Q48858683 | ||
| Serial measurement of interleukin-6, transforming growth factor-beta, and S-100 protein in patients with acute stroke | Q48937093 | ||
| Oxfordshire community stroke project classification poorly differentiates small cortical and subcortical infarcts. | Q49132410 | ||
| [Changes of protein S100B serum concentration during ischemic and hemorrhagic stroke in relation to the volume of stroke lesion]. | Q53574086 | ||
| Comparison of serum S-100 protein levels following stroke and traumatic brain injury | Q62053785 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 395-400 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | Noropsikiyatri Arsivi | Q15760068 |
| P1476 | title | The Relationship of Serum S100B Levels with Infarction Size and Clinical Outcome in Acute Ischemic Stroke Patients | |
| P478 | volume | 51 |
| Q49539382 | Association of S100B polymorphisms and serum S100B with risk of ischemic stroke in a Chinese population |
| Q93187334 | Blood biomarkers for physical recovery in ischemic stroke: a systematic review |
| Q64071461 | Expression of S100B Protein in Ischemia/Reperfusion-Induced Brain Injury After Cyclosporine Therapy: A Biochemical Serum Marker with Prognostic Value? |
| Q92615800 | LDL Subclasses in Ischemic Stroke: A Risk Factor? |
| Q92519199 | Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody |
Search more.